
Quantum Genomics
ALQGC | PA
Overview
Corporate Details
- ISIN(s):
- FR0010783837 (+4 more)
- LEI:
- 969500TFCD8K9RPM9K97
- Country:
- France
- Address:
- 6 RUE CAMBACERES, 75008 PARIS
- Website:
- https://quantum-genomics.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high blood pressure and heart failure. Quantum Genomics is developing a new therapeutic approach based on Brain Aminopeptidase A inhibition (BAPAI) , which results from more than twenty years of academic research in the laboratories of the Collège de France, INSERM and CNRS. The research conducted by the team of Professor Bernard-Pierre Roques (INSERM U1022 / CNRS Unit/ Université Paris Descartes) and the team of Dr. Catherine Llorens-Cortes (INSERM U1050 / Collège de France) characterized the role of the brain renin-angiotensin system (RAS) and more particularly that of aminopeptidase A (APA) in the control of certain cardiovascular functions including blood pressure.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Quantum Genomics.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-13 18:00 |
Post-Annual General Meeting Information
Report de l'Assemblée Générale Mixte du 30/06/2025
|
French | 116.4 KB | |
2025-04-30 20:00 |
Earnings Release
Quantum Genomics publishes its 2024 annual financial statements and announces a…
|
English | 206.5 KB | |
2025-04-30 20:00 |
Delisting Announcement
Quantum Genomics publie ses comptes annuels 2024 et annonce un changement de li…
|
French | 254.0 KB | |
2025-04-08 08:00 |
Delisting Announcement
Quantum Genomics fait un point sur sa situation
|
French | 688.8 KB | |
2025-04-08 08:00 |
Delisting Announcement
Quantum Genomics provides an update on its situation
|
English | 626.0 KB | |
2024-10-29 18:00 |
Earnings Release
Quantum Genomics publie ses résultats du 1er semestre 2024 et annonce la nomina…
|
French | 241.2 KB | |
2024-09-27 08:00 |
Legal Proceedings Report
Quantum Genomics sécurise un financement avec le fonds Akkadian Partners Fund e…
|
French | 74.5 KB | |
2024-09-04 18:00 |
Legal Proceedings Report
Quantum Genomics reviewed its financial situation and announced that it has fil…
|
English | 175.5 KB | |
2024-09-04 18:00 |
Legal Proceedings Report
Quantum Genomics fait un point sur sa situation financière et annonce qu'elle a…
|
French | 150.0 KB | |
2024-07-03 13:00 |
Capital/Financing Update
BILAN SEMESTRIEL S1 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE…
|
French | 275.3 KB | |
2024-03-13 18:00 |
Business and Financial Review
Quantum Genomics publie ses résultats de l'exercice 2023. Le rapprochement avec…
|
French | 193.8 KB | |
2024-03-13 18:00 |
Earnings Release
Quantum Genomics publishes its results for the 2023 financial year. The merger …
|
English | 166.3 KB | |
2024-01-10 16:35 |
Capital/Financing Update
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | |
2024-01-10 16:30 |
Capital/Financing Update
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | |
2023-12-14 18:05 |
Regulatory News Service
Quantum Genomics enters into exclusive negotiations with ExactCure
|
English | 286.1 KB |
Automate Your Workflow. Get a real-time feed of all Quantum Genomics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Quantum Genomics via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Double Bond Pharmaceutical International AB | Sweden | DBP B | |
|
Eckert & Ziegler Strahlen- und Medizintechnik AG | Germany | EUZ | |
![]() |
Ectin Research AB | Sweden | ECTIN B | |
![]() |
Elanix Biotechnologies AG | Germany | ELN | |
![]() |
Elbit Meditec-M Ltd. | Israel | EMTC-M | |
![]() |
Elicera Therapeutics AB | Sweden | ELIC | |
![]() |
Elron Ventures Ltd. | Israel | ELRN | |
![]() |
Enlivex Therapeutics Ltd. | Israel | ENLV | |
![]() |
ERYTECH Pharma S.A. | France | ERYP | |
![]() |
Eurobio Scientific | France | ALERS |